Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation

Dev Cell. 2006 May;10(5):563-73. doi: 10.1016/j.devcel.2006.03.004.

Abstract

Mouse knockouts of Cdk2 and Cdk4 have demonstrated that, individually, these genes are not essential for viability. To investigate whether there is functional redundancy, we have generated double knockout (DKO) mice. Cdk2-/- Cdk4-/- DKOs die during embryogenesis around E15 as a result of heart defects. We observed a gradual decrease of Retinoblastoma protein (Rb) phosphorylation and reduced expression of E2F-target genes, like Cdc2 and cyclin A2, during embryogenesis and in embryonic fibroblasts (MEFs). DKO MEFs are characterized by a decreased proliferation rate, impaired S phase entry, and premature senescence. HPV-E7-mediated inactivation of Rb restored normal expression of E2F-inducible genes, senescence, and proliferation in DKO MEFs. In contrast, loss of p27 did not rescue Cdk2-/- Cdk4-/- phenotypes. Our results demonstrate that Cdk2 and Cdk4 cooperate to phosphorylate Rb in vivo and to couple the G1/S phase transition to mitosis via E2F-dependent regulation of gene expression.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Cell Proliferation
  • Cells, Cultured
  • Cyclin-Dependent Kinase 2 / deficiency*
  • Cyclin-Dependent Kinase 2 / genetics
  • Cyclin-Dependent Kinase 4 / deficiency*
  • Cyclin-Dependent Kinase 4 / genetics
  • E2F Transcription Factors / antagonists & inhibitors
  • Embryo, Mammalian / abnormalities*
  • Fibroblasts / cytology
  • Gene Silencing
  • Hematopoiesis
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oncogene Proteins, Viral / metabolism
  • Papillomavirus E7 Proteins
  • Phenotype
  • Phosphorylation
  • Retinoblastoma Protein / antagonists & inhibitors
  • Retinoblastoma Protein / chemistry
  • Retinoblastoma Protein / metabolism*

Substances

  • E2F Transcription Factors
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • Retinoblastoma Protein
  • oncogene protein E7, Human papillomavirus type 16
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 4